Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Nancy N. Baxter, Erin B. Kennedy, Emily K. Bergsland, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 8, pp. 892-910
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K. Morris, Erin B. Kennedy, Nancy N. Baxter, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 3, pp. 678-700
Open Access | Times Cited: 314
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
Dion Morton, Michel Seymour, Laura Magill, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 8, pp. 1541-1552
Open Access | Times Cited: 229
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
Myriam Chalabi, Y.L. Verschoor, Pedro Batista Tan, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 21, pp. 1949-1958
Closed Access | Times Cited: 103
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
Shaobo Mo, Ye Li, Dongyang Wang, et al.
JAMA Oncology (2023) Vol. 9, Iss. 6, pp. 770-770
Open Access | Times Cited: 55
Colorectal cancer
Cathy Eng, Takayuki Yoshino, Érika Ruiz-García, et al.
The Lancet (2024) Vol. 404, Iss. 10449, pp. 294-310
Closed Access | Times Cited: 47
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 17
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
Andreas Kleppe, Ole-Johan Skrede, Sepp de Raedt, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 9, pp. 1221-1232
Closed Access | Times Cited: 57
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
Ting Chan, Satoshi Nagayama, Masumi Otaki, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 35
Regulatory implications of ctDNA in immuno-oncology for solid tumors
Paz J. Vellanki, Soma Ghosh, Anand Pathak, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005344-e005344
Open Access | Times Cited: 27
Radiomics in colorectal cancer patients
Riccardo Inchingolo, Cesare Maino, Roberto Cannella, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 19, pp. 2888-2904
Open Access | Times Cited: 25
Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 15
Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis
Durgesh Wankhede, Tanwei Yuan, Matthias Kloor, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 7, pp. 609-619
Closed Access | Times Cited: 13
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation
Priyadarshini Pathak, Gloria Chan, Dustin A. Deming, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 10
Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence
Kun-Yu Tsai, Po-Shuan Huang, Po-Yu Chu, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2316-2316
Open Access | Times Cited: 8
Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay
Yoshiaki Nakamura, Yuichiro Tsukada, Nobuhisa Matsuhashi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 19, pp. 4377-4387
Open Access | Times Cited: 8
Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging
Klaus Gerwert, Stephanie Schörner, Frederik Großerueschkamp, et al.
European Journal of Cancer (2023) Vol. 182, pp. 122-131
Closed Access | Times Cited: 16
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
Alessandro Mannucci, Ajay Goel
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
M. Polack, Marloes Smit, Gabi W. van Pelt, et al.
ESMO Open (2024) Vol. 9, Iss. 4, pp. 102988-102988
Open Access | Times Cited: 6
Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival
Reetesh K. Pai, Imon Banerjee, Sameer Shivji, et al.
Gastroenterology (2022) Vol. 163, Iss. 6, pp. 1531-1546.e8
Open Access | Times Cited: 22
A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer
Min Li, Congcong Zhu, Ying Xue, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 9, pp. 1681-1689
Closed Access | Times Cited: 14
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Yonghong Li, Avneet K. Heer, Hillary S. Sloane, et al.
JAMA Health Forum (2024) Vol. 5, Iss. 5, pp. e241270-e241270
Open Access | Times Cited: 5
Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer
Bruna Costa, Marta F Estrada, António Gomes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Prognosis in stage II colon cancer: Expanding the horizons of risk factors
María Belén Novoa Díaz, Claudia Gentili, María Julia Martín, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing
Krunal Pawar, Pramodkumar P. Gupta, Pooran Singh Solanki, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 67-67
Open Access
Survival Benefit of Adjuvant Chemotherapy in Stage II Large (≥5 cm) Colonic Adenocarcinomas: a Propensity-Score Matched Analysis
Sameh Hany Emile, Nir Horesh, Zoe Garoufalia, et al.
Surgical Oncology (2025), pp. 102190-102190
Closed Access
Page 1 - Next Page

Scroll to top